Intelligent Bio Solutions Showcases Rapid, Non-Invasive Drug Testing Capabilities in Remote Queensland Workforce Deployment
Intelligent Bio Solutions (NASDAQ: INBS) successfully completed a large-scale workforce drug testing operation at Barcaldine Regional Council in remote Queensland, Australia, using its Intelligent Fingerprinting Drug Screening System. The company tested 160 employees in under 90 minutes, demonstrating significant efficiency compared to traditional testing methods.
The fingerprint-based system delivered rapid results in under 10 minutes per test, allowing the entire workforce to be cleared for duty before 8:00 a.m. The Council has now been trained for in-house random testing, with plans for continued workforce testing through INBS's on-site model. The company currently serves over 450 accounts across 24 countries, marking this successful deployment as a strategic expansion into regional and remote workforce testing markets.
Intelligent Bio Solutions (NASDAQ: INBS) ha completato con successo un'operazione su larga scala di test antidroga per la forza lavoro presso il Barcaldine Regional Council, nella remota Queensland, Australia, utilizzando il suo Sistema di Screening Antidroga tramite Impronte Digitali Intelligenti. L'azienda ha testato 160 dipendenti in meno di 90 minuti, dimostrando un'efficienza significativa rispetto ai metodi tradizionali.
Il sistema basato sulle impronte digitali ha fornito risultati rapidi in meno di 10 minuti per test, permettendo a tutto il personale di essere idoneo al lavoro prima delle 8:00 del mattino. Il Consiglio è stato ora formato per effettuare test casuali interni, con piani per continuare i test della forza lavoro tramite il modello on-site di INBS. Attualmente, l'azienda serve oltre 450 clienti in 24 paesi, segnando questo successo come un'espansione strategica nei mercati di test per le forze lavoro regionali e remote.
Intelligent Bio Solutions (NASDAQ: INBS) completó con éxito una operación a gran escala de pruebas de drogas en la fuerza laboral del Barcaldine Regional Council en la remota Queensland, Australia, utilizando su Sistema de Detección de Drogas mediante Huellas Dactilares Inteligentes. La compañía examinó a 160 empleados en menos de 90 minutos, demostrando una eficiencia significativa en comparación con los métodos tradicionales.
El sistema basado en huellas digitales entregó resultados rápidos en menos de 10 minutos por prueba, permitiendo que toda la fuerza laboral estuviera autorizada para trabajar antes de las 8:00 a.m. El Consejo ahora ha sido capacitado para realizar pruebas aleatorias internas, con planes para continuar las pruebas de la fuerza laboral a través del modelo en sitio de INBS. Actualmente, la empresa atiende a más de 450 cuentas en 24 países, marcando este despliegue exitoso como una expansión estratégica en los mercados de pruebas para fuerzas laborales regionales y remotas.
Intelligent Bio Solutions (NASDAQ: INBS)는 호주 퀸즐랜드의 외딴 지역인 Barcaldine Regional Council에서 자사의 지능형 지문 약물 검사 시스템을 사용하여 대규모 인력 약물 검사 작업을 성공적으로 완료했습니다. 회사는 160명의 직원을 90분 이내에 검사하여 전통적인 검사 방법에 비해 뛰어난 효율성을 입증했습니다.
지문 기반 시스템은 테스트당 10분 이내에 빠른 결과를 제공하여 전체 인력이 오전 8시 이전에 근무 허가를 받을 수 있었습니다. 이 위원회는 이제 내부 무작위 검사를 위한 교육을 받았으며, INBS의 현장 모델을 통한 인력 검사 지속 계획을 가지고 있습니다. 현재 회사는 24개국에서 450개 이상의 계정을 지원하며, 이번 성공적인 배치는 지역 및 외딴 인력 검사 시장으로의 전략적 확장으로 평가됩니다.
Intelligent Bio Solutions (NASDAQ : INBS) a mené avec succès une opération de dépistage de drogues à grande échelle auprès des employés du Barcaldine Regional Council, situé dans le Queensland éloigné en Australie, en utilisant son système de dépistage par empreintes digitales intelligentes. L'entreprise a testé 160 employés en moins de 90 minutes, démontrant une efficacité significative par rapport aux méthodes traditionnelles.
Le système basé sur les empreintes digitales a fourni des résultats rapides en moins de 10 minutes par test, permettant à l'ensemble du personnel d'être autorisé à travailler avant 8h00. Le conseil a désormais été formé pour effectuer des tests aléatoires en interne, avec des plans pour poursuivre les tests de la main-d'œuvre via le modèle sur site d'INBS. L'entreprise dessert actuellement plus de 450 comptes dans 24 pays, faisant de ce déploiement réussi une expansion stratégique vers les marchés des tests pour les travailleurs en régions éloignées et rurales.
Intelligent Bio Solutions (NASDAQ: INBS) hat erfolgreich eine groß angelegte Drogentests bei der Belegschaft des Barcaldine Regional Council im abgelegenen Queensland, Australien, mit seinem Intelligent Fingerprinting Drug Screening System durchgeführt. Das Unternehmen testete 160 Mitarbeiter in weniger als 90 Minuten und zeigte damit eine deutlich höhere Effizienz im Vergleich zu traditionellen Testmethoden.
Das auf Fingerabdrücken basierende System lieferte schnelle Ergebnisse in weniger als 10 Minuten pro Test, sodass die gesamte Belegschaft vor 8:00 Uhr morgens einsatzbereit war. Der Rat wurde nun für interne Zufallstests geschult, mit Plänen, die Belegschaft weiterhin durch das Vor-Ort-Modell von INBS zu testen. Das Unternehmen betreut derzeit über 450 Kunden in 24 Ländern und markiert diesen erfolgreichen Einsatz als strategische Expansion in den Markt für regionale und abgelegene Arbeitstests.
- Successfully tested 160 employees in under 90 minutes, demonstrating superior efficiency
- Expansion into new market segment of regional and remote workforce testing
- System provides results in under 10 minutes per test
- Growing presence with over 450 accounts across 24 countries
- Secured ongoing business through training Council for in-house random testing
- None.
Insights
INBS demonstrates superior drug testing efficiency in remote setting, validating technology's commercial viability and market expansion potential.
Intelligent Bio Solutions has achieved a significant operational milestone with its fingerprint-based drug testing system. The successful deployment at Barcaldine Regional Council demonstrated remarkable efficiency: testing 160 employees in under 90 minutes – a throughput impossible with traditional methods. This deployment showcases several compelling technological advantages over conventional urine and saliva testing approaches.
The fingerprint system eliminates major operational bottlenecks that plague traditional methods, including the need for private collection facilities, supervised sample collection, nil-by-mouth waiting periods for saliva tests, and the notorious "shy bladder" delays that can extend urine testing by up to three hours per employee. These advantages translate directly to workforce productivity savings.
What's particularly notable is the successful implementation in a remote Queensland location, proving the technology's versatility in challenging environments where traditional testing logistics become especially problematic. The company's dual approach – offering both managed testing services and training clients for in-house testing – creates multiple revenue streams while building client dependency on their technology ecosystem.
The client's positive feedback regarding both operational efficiency and confirmation accuracy rates validates two critical performance metrics. With a global footprint already spanning 450 accounts across 24 countries, this successful expansion into remote workforce testing represents a logical market extension rather than a speculative new direction. The non-invasive nature of the technology addresses growing privacy concerns in workplace testing while simultaneously improving operational metrics – a rare combination that strengthens the company's competitive positioning in the evolving workplace safety market.
Completion of 160 tests conducted in less than 90 minutes demonstrates a level of speed and efficiency beyond the limits of traditional testing approaches
NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the successful completion of a high-volume workforce drug test for Barcaldine Regional Council in remote Queensland, Australia, (the “Council”) using its Intelligent Fingerprinting Drug Screening System (the “System”). This initiative supports the Company's expansion into regional and remote workforce testing markets.
In less than 90 minutes, more than 160 employees, representing
“The level of speed and efficiency we have shown here simply isn’t possible with traditional testing methods,” said Doug Heath, Global Vice President of Sales at Intelligent Bio Solutions. “If the Council had relied on urine or saliva testing, the process would likely have disrupted operations for over a day. Traditional testing requires private facilities, supervised collection, and nil-by-mouth waiting periods for saliva testing. If urine testing, delays caused by ‘shy bladder’ procedures can extend the process by up to three hours per donor, requiring restricted water intake, constant monitoring, and multiple collection attempts to achieve a valid sample. With confirmation and chain-of-custody requirements, these methods could have extended testing across multiple shifts.”
INBS delivered a comprehensive on-site collect-and-test service, demonstrating its capability to deliver testing anywhere, anytime, including in remote locations. The System’s speed and non-invasive nature enabled testing to be completed before 8:00 a.m., well ahead of the full day allocated, allowing Council staff to resume work immediately. The Council expressed satisfaction with the confirmation rate of non-negative results, validating the System’s high level of accuracy.
“INBS’ process was handled professionally from start to finish,” said Adele Bintley, Manager of People, Culture and Organizational Performance at Barcaldine Regional Council. “We were impressed by how quickly testing was completed and how seamlessly the entire process was coordinated. It’s an excellent solution for remote councils like ours.”
Following the initial test, Council personnel were trained to conduct random testing in-house, with plans for complete workforce tests to continue through the Company's on-site testing model. This deployment has opened a new market for the Company, showing that a fully managed, on-location service is viable and valuable in regional settings.
“The ability to test an entire workforce in such a short window and still achieve high levels of accuracy is a key benefit of our fingerprint-based system,” continued Doug Heath, Global Vice President of Sales at Intelligent Bio Solutions. “It supports safer workplaces without compromising productivity, particularly in regional and remote areas where traditional methods can be logistically and operationally challenging.”
This successful rollout expands on the Company’s growth efforts across the Asia-Pacific region, with further expansion expected as demand for safer, faster, and more practical workplace drug testing continues to rise. The Company's Intelligent Fingerprinting Drug Screening System is designed to detect recent drug use through fingerprint sweat analysis, providing results in under ten minutes. With over 450 accounts across 24 countries, INBS continues to lead the evolution of drug screening technology, serving industries including construction, manufacturing, transport, and logistics.
About Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company delivering intelligent, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for the recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries. The Company’s current customer segments outside the US include construction, manufacturing and engineering, transport and logistics firms, mining, drug treatment organizations, and coroners.
For more information, visit: http://www.ibs.inc/
Forward-Looking Statements
Some of the statements in this release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements in this press release include, without limitation, Intelligent Bio Solutions Inc.’s ability to successfully develop and commercialize its drug and diagnostic tests, realize commercial benefit from its partnerships and collaborations, and secure regulatory approvals, among others. Although Intelligent Bio Solutions Inc. believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. Intelligent Bio Solutions Inc. has attempted to identify forward-looking statements by terminology, including “believes,” “estimates,” “anticipates,” “expects,” “plans,” “projects,” “intends,” “potential,” “may,” “could,” “might,” “will,” “should,” “approximately” or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, included in Intelligent Bio Solutions’ public filings filed with the Securities and Exchange Commission. Any forward-looking statements contained in this release speak only as of its date. Intelligent Bio Solutions undertakes no obligation to update any forward-looking statements contained in this release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events.
Company Contact:
Intelligent Bio Solutions Inc.
info@ibs.inc
LinkedIn | Twitter
Investor & Media Contact:
Valter Pinto, Managing Director
KCSA Strategic Communications
PH: (212) 896-1254
INBS@kcsa.com
FAQ
How long did it take INBS to test 160 employees at Barcaldine Regional Council?
What are the advantages of INBS fingerprint drug testing over traditional methods?
How many accounts does Intelligent Bio Solutions (INBS) currently serve?
How quickly does the INBS Intelligent Fingerprinting Drug Screening System provide results?
What industries does INBS drug screening technology serve?
